Literature DB >> 21470463

Molecular discrimination of sheep bovine spongiform encephalopathy from scrapie.

Laura Pirisinu1, Sergio Migliore, Michele Angelo Di Bari, Elena Esposito, Thierry Baron, Claudia D'Agostino, Luigi De Grossi, Gabriele Vaccari, Umberto Agrimi, Romolo Nonno.   

Abstract

Sheep CH1641-like transmissible spongiform encephalopathy isolates have shown molecular similarities to bovine spongiform encephalopathy (BSE) isolates. We report that the prion protein PrPSc from sheep BSE is extremely resistant to denaturation. This feature, combined with the N-terminal PrPSc cleavage, allowed differentiation of classical scrapie, including CH1641-like, from natural goat BSE and experimental sheep BSE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21470463      PMCID: PMC3377410          DOI: 10.3201/eid1704.101215

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Prion diseases, or transmissible spongiform encephalopathies (TSEs), are neurodegenerative disorders that include Creutzfeldt-Jakob disease (CJD) in humans, scrapie in sheep and goats, and bovine spongiform encephalopathy (BSE) in cattle. TSEs are characterized by accumulation of an abnormal isoform of the host-encoded prion protein (PrPC), termed PrPSc. A novel human prion disease, variant CJD, was reported in 1995 and postulated to be caused by eating beef infected with BSE. Biologic and molecular analyses provided evidence that the same agent was involved in BSE and variant CJD (,). Evidence of sheep and goat susceptibility to BSE () and discovery of natural BSE infections in 2 goats (,) prompted the European Commission to increase the search for BSE infections in small ruminants. Although the BSE agent can be recognized by biologic strain typing in conventional mice (), large-scale testing of small ruminants required molecular tests able to discriminate BSE from the most common TSEs of small ruminants. Molecular criteria used to discriminate BSE from scrapie are based on the low molecular weight of proteinase K–treated PrPSc (PrPres) (–), a high proportion of the diglycosylated PrPSc (,,), and poor or absent binding with antibodies directed at N-terminal epitopes (–). This last characteristic was fundamental in developing the discriminatory methods currently approved for surveillance in Europe (). The experimental scrapie isolate CH1641 reportedly shares molecular features with experimental sheep BSE (), although lack of transmissibility of CH1641 to conventional mice in comparison to successful transmission of BSE provided evidence that CH1641 and BSE are caused by distinct prion agents. A few natural isolates have been described in sheep, showing molecular (,) and biologic () similarities to CH1641, and were named CH1641-like. Subtle pathologic differences were exploited to distinguish these CH1641-like isolates from BSE by immunohistochemical (,) and biochemical analyses by glycoform profiling (,). However, routine testing by using discriminatory Western blot (WB) methods does not easily distinguish CH1641 and CH1641-like isolates from BSE (,). We report 2 new CH1641-like isolates; analyze the conformational stability of CH1641-like isolates, BSE, and classical scrapie; and show that a reliable molecular differentiation of these 3 TSE sources is possible by an improved discriminatory WB method.

The Study

During 2009–2010, we analyzed conformational stability of PrPSc from sheep TSE isolates by using a conformational stability and solubility assay (CSSA) that we developed (). We showed that CSSA could reveal strain-specified PrPSc conformational stability in sheep isolates because it enabled discrimination of Nor98 from classical scrapie isolates (). Scrapie isolates had GdnHCl1/2 values (the concentration of guanidine hydrochloride able to dissolve half the insoluble PrPSc aggregates in a brain homogenate) of 2.0 mol/L–2.3 mol/L; Nor98 isolates were less stable (1.3–1.4 mol/L GdnHCl). We thus sought to determine the conformational stability of PrPSc aggregates (Technical Appendix) derived from CH1641 and BSE strains (Table 1), including one (TR316211) of the few CH1641-like field isolates described so far (,,). Two other CH1641-like isolates (99–454 and 99–321) were found in a retrospective analysis of sheep scrapie cases in France.
Table 1

Transmissible spongiform encephalopathy isolates analyzed by conformational stability and solubility assay*

SourceIdentification no.PrP genotype†GdnHCl1/2, mol/L ± SD‡
Natural isolates
ScrapieES/8/10/2ARQ/ARQ2.19 ± 0.18
CH1641-like99–454VRQ/VRQ2.00 ± 0.06
99–321VRQ/VRQ2.41 ± 0.49

TR316211
ARQ/ARQ
2.82 ± 0.08
Experimental samples
CH1641241/74AxQ/AxQ2.07 ± 0.05
Sheep BSE301/16§ARQ/ARQ>4
301/44§ARQ/ARQ>4
302/90¶ARQ/ARQ3.8; >4; >4

*PrP, prion protein; GdnHCL1/2, guanidine hydrochloride at a concentration able to dissolve half the insoluble aggregates in a brain homogenate; BSE, bovine spongiform encephalopathy.
†Amino acids at codons 136, 154 and 171.
‡Each sample was analyzed >3 times.
§Intracerebral transmission.
¶Oral transmission.

*PrP, prion protein; GdnHCL1/2, guanidine hydrochloride at a concentration able to dissolve half the insoluble aggregates in a brain homogenate; BSE, bovine spongiform encephalopathy.
†Amino acids at codons 136, 154 and 171.
‡Each sample was analyzed >3 times.
§Intracerebral transmission.
¶Oral transmission. Classical scrapie included as control displayed a GdnHCl1/2 value (2.2 mol/L) in the range of previously analyzed isolates. CH1641 (provided by N. Hunter, Institute for Animal Health, Edinburgh, Scotland) and CH1641-like isolates showed conformational stabilities close to classical scrapie, with GdnHCl1/2 values of 2.0–2.8 mol/L. In contrast, PrPSc from experimental sheep BSE () clearly showed higher conformational stability, with GdnHCl1/2 values >3.8 mol/L (Table 1). These results suggest experimental sheep BSE might have a stronger resistance to denaturation than do most natural sheep scrapie isolates. Because the discriminatory methods based on differential PrPSc N-terminal proteinase K (PK) cleavage () do not enable a clear-cut discrimination of CH1641-like from BSE (), we investigated the potential of denaturation with GdnHCl as a further discriminatory strategy within the framework of the Istituto Superiore di Sanità discriminatory WB (). To this aim, samples were untreated or treated with 3.5 mol/L GdnHCl before PK digestion and WB analysis with SAF84 and P4 monoclonal antibodies (Figure 1). This method was set up by analyzing representative scrapie, BSE, and CH1641 samples (Figure 1). As expected, BSE and CH1641 were poorly detected by P4, in contrast to classical scrapie. Treatment with 3.5 M GdnHCl, however, nearly abolished PK resistance of PrPSc from classical scrapie and CH1641, but not from sheep BSE, thus also enabling discrimination of CH1641 from BSE.
Figure 1

Representative Western blot showing the differential N-terminal proteinase K cleavage (monoclonal antibodies SAF84 vs. P4) and the susceptibility to denaturation of different transmissible spongiform encephalopathy isolates. Samples are indicated according to Table 2: classical scrapie isolates (Sc1, Sc2, Sc3, Sc4); experimental CH1641 (Ch1); CH1641-like isolates (Ch2, Ch3, Ch4); experimental sheep bovine spongiform encephalopathy by intracerebral transmission (Bs1) and oral transmission (Bs2, Bs3, Bs4, Bs5); natural goat isolate (Bs6). All samples were pretreated (+) or not treated (-) with 3.5 mol/L guanidine hydrochloride for 1 h at 37°C and then diluted to a final concentration of 0.35 mol/L guanidine hydrochloride, before digestion with proteinase K according to the Istituto Superiore di Sanità discriminatory method. Replica blots were probed with SAF84 (top) and P4 (bottom). Molecular weights are indicated on the right. GdnHCl, guanidine hydrochloride.

Representative Western blot showing the differential N-terminal proteinase K cleavage (monoclonal antibodies SAF84 vs. P4) and the susceptibility to denaturation of different transmissible spongiform encephalopathy isolates. Samples are indicated according to Table 2: classical scrapie isolates (Sc1, Sc2, Sc3, Sc4); experimental CH1641 (Ch1); CH1641-like isolates (Ch2, Ch3, Ch4); experimental sheep bovine spongiform encephalopathy by intracerebral transmission (Bs1) and oral transmission (Bs2, Bs3, Bs4, Bs5); natural goat isolate (Bs6). All samples were pretreated (+) or not treated (-) with 3.5 mol/L guanidine hydrochloride for 1 h at 37°C and then diluted to a final concentration of 0.35 mol/L guanidine hydrochloride, before digestion with proteinase K according to the Istituto Superiore di Sanità discriminatory method. Replica blots were probed with SAF84 (top) and P4 (bottom). Molecular weights are indicated on the right. GdnHCl, guanidine hydrochloride.
Table 2

Transmissible spongiform encephalopathy samples analyzed by discriminatory Western blot*

SourceIdentification no.PrP genotype†Blot
lane
Natural isolates
ScrapieES16/10/10ARQ/ARQSc1
ES16/10/11ARQ/ARQSc2
ES16/10/12ARQ/ARQSc3
ES12/10/1ARQ/ARQ
ES12/10/2ARQ/ARQ
ES12/10/3ARQ/ARQSc4
CH1641-like99–454VRQ/VRQCh2
99–321VRQ/VRQCh4
TR316211ARQ/ARQCh3
Goat BSE
CH636

Bs6
Experimental samples
CH1641241/74AxQ/AxQCh1
Sheep BSE301/16‡ARQ/ARQBs1
301/44‡ARQ/ARQ
302/87§ARQ/ARQBs3
302/130§ARQ/ARQBs4
302/64§ARQ/AHQBs5
302/90§ARQ/ARQBs2

*Blot lanes shown in Figure 1. PrP, prion protein; BSE, bovine spongiform encephalopathy.
†Amino acids at codons 136, 154 and 171.
‡Intracerebral transmission.
§Oral transmission.

We then analyzed a larger set of samples (Table 2), including natural BSE in a goat (Figure 1). These experiments confirmed the higher resistance to denaturation of BSE samples, irrespective of the species, PrP genotype, and route of inoculation, compared with all other samples (Figure 1). When the antibody ratio and the denaturation ratio were measured and plotted as a scattergraph, classical scrapie, CH1641, and BSE isolates clustered into 3 distinct groups (Figure 2, panel A): 1) scrapie isolates displayed antibody ratios <2 and denaturation ratios were 0.02–0.13; 2) CH1641 samples had antibody ratios >2 and denaturation ratios were 0.06–0.29; and 3) BSE samples had antibody ratios >2, but denaturation ratios were >0.51.
Figure 2

A) Scattergraph of antibody ratio and denaturation ratio obtained from each sample in Table 2, showing discrimination of scrapie, CH1641, CH1641-like, and bovine spongiform encephalopathy (BSE) samples. The antibody ratio is the SAF84/P4 ratio of the chemiluminescence signal relative to the SAF84/P4 ratio of the control scrapie loaded in each blot (Technical Appendix). The denaturation ratio, obtained from the SAF84 blot, is the ratio between the chemiluminescence signal with 3.5 mol/L and that with 0 mol/L. The vertical dashed line refers to the cutoff value of the antibody ratio, according to the Istituto Superiore di Sanità discriminatory Western blot (antibody ratio 2). The horizontal dashed line (denaturation ratio 0.4) shows the separation of BSE samples from all other transmissible spongiform encephalopathy sources. B) Scattergraph of proportions of diglycosylated and monoglycosylated PrPres bands from samples in Table 2. Results were obtained from guanidine hydrochloride–untreated samples in blots treated with SAF84. Classical scrapie samples are represented by black symbols, CH1641 by red symbols, and BSE samples by blue symbols. Filled symbols denote natural isolates and open symbols represent the experimental isolates.

*Blot lanes shown in Figure 1. PrP, prion protein; BSE, bovine spongiform encephalopathy.
†Amino acids at codons 136, 154 and 171.
‡Intracerebral transmission.
§Oral transmission. A) Scattergraph of antibody ratio and denaturation ratio obtained from each sample in Table 2, showing discrimination of scrapie, CH1641, CH1641-like, and bovine spongiform encephalopathy (BSE) samples. The antibody ratio is the SAF84/P4 ratio of the chemiluminescence signal relative to the SAF84/P4 ratio of the control scrapie loaded in each blot (Technical Appendix). The denaturation ratio, obtained from the SAF84 blot, is the ratio between the chemiluminescence signal with 3.5 mol/L and that with 0 mol/L. The vertical dashed line refers to the cutoff value of the antibody ratio, according to the Istituto Superiore di Sanità discriminatory Western blot (antibody ratio 2). The horizontal dashed line (denaturation ratio 0.4) shows the separation of BSE samples from all other transmissible spongiform encephalopathy sources. B) Scattergraph of proportions of diglycosylated and monoglycosylated PrPres bands from samples in Table 2. Results were obtained from guanidine hydrochloride–untreated samples in blots treated with SAF84. Classical scrapie samples are represented by black symbols, CH1641 by red symbols, and BSE samples by blue symbols. Filled symbols denote natural isolates and open symbols represent the experimental isolates. Glycoform profiles, i.e., the relative proportion of diglycosylated, monoglycosylated, and unglycosylated PrPres fragments, have also been reported as a discriminatory criterion for the identification of BSE in sheep (–), as well as when compared with CH1641 (,). With the Istituto Superiore di Sanità WB method (Figure 2, panel B), field scrapie isolates, including CH1641-like isolates, were characterized by a lower diglycosylated-to-monoglycosylated glycoform ratio (0.48:0.35–0.58:0.25) than sheep BSE (0.65:0.25–0.75:0.19) and the natural goat BSE (0.70:0.22).

Conclusions

Because the analysis of PrPSc from sheep prion isolates by CSSA showed an extremely high conformational stability of BSE samples, we improved the Istituto Superiore di Sanità discriminatory WB by including a pretreatment of brain homogenates with GdnHCl. Our results show that the combined use of 2 independent molecular features, N-terminal cleavage by PK and resistance to denaturation, could indeed differentiate classical scrapie and CH1641-like isolates from small ruminant BSE. Nonetheless, we observed some variability among the CH1641-like samples, either when analyzed by CSSA (Table 1) or by the discriminatory WB. As previously reported (), the antibody ratios of some CH1641-like samples were close to the cutoff (Figure 2, panel A). Furthermore, the variable conformational stability observed by CSSA was also reflected in the denaturation ratios measured by discriminatory WB, with 2 CH1641-like samples showing a relatively higher resistance to GdnHCl than to all other scrapie samples. Because of the limited number of CH1641-like isolates, further studies are needed to evaluate their effective range of variability. This variability may be disappointing for discriminatory purposes, but it may also hinder the possible presence of subtle PrPSc conformational (and possibly strain) variants in CH1641-like isolates. The biologic similarities of CH1641-like samples after transmission to ovine transgenic mice () and voles (U. Agrimi, unpub. data) were worth noting. Nevertheless, CH1641-like isolates induced a certain degree of PrPSc molecular variability in both rodent models (13; U. Agrimi, unpub. data), which might be related to the molecular variability in PrPSc extracted from sheep brain. Although based on a limited set of samples, our study supports the notion that CH1641-like isolates can be convincingly discriminated from small ruminant BSE on molecular grounds. Furthermore, the high conformational stability of BSE, when compared with that in classical scrapie, Nor98, and CH1641-like isolates, suggests the potential of the new discriminatory WB here proposed for discriminating BSE from other known small ruminant TSEs.

Technical Appendix

Provides additional information on the Determination of the SAF84/P4 antibody ratio.
  14 in total

1.  BSE agent signatures in a goat.

Authors:  Marc Eloit; Karim Adjou; Muriel Coulpier; Jean Jacques Fontaine; Rodolphe Hamel; Thomas Lilin; Sebastien Messiaen; Olivier Andreoletti; Thierry Baron; Anna Bencsik; Anne Gaelle Biacabe; Vincent Beringue; Hubert Laude; Annick Le Dur; Jean Luc Vilotte; Emmanuel Comoy; Jean Philippe Deslys; Jacques Grassi; Stephanie Simon; Frederic Lantier; Pierre Sarradin
Journal:  Vet Rec       Date:  2005-04-16       Impact factor: 2.695

2.  Comparison of French natural scrapie isolates with bovine spongiform encephalopathy and experimental scrapie infected sheep.

Authors:  T G Baron; J Y Madec; D Calavas; Y Richard; F Barillet
Journal:  Neurosci Lett       Date:  2000-04-28       Impact factor: 3.046

3.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

Authors:  J Collinge; K C Sidle; J Meads; J Ironside; A F Hill
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

4.  Differentiation of prion protein glycoforms from naturally occurring sheep scrapie, sheep-passaged scrapie strains (CH1641 and SSBP1), bovine spongiform encephalopathy (BSE) cases and Romney and Cheviot breed sheep experimentally inoculated with BSE using two monoclonal antibodies.

Authors:  Michael James Stack; Melanie Jane Chaplin; Jemma Clark
Journal:  Acta Neuropathol       Date:  2002-06-26       Impact factor: 17.088

5.  A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc.

Authors:  Laura Pirisinu; Michele Di Bari; Stefano Marcon; Gabriele Vaccari; Claudia D'Agostino; Paola Fazzi; Elena Esposito; Roberta Galeno; Jan Langeveld; Umberto Agrimi; Romolo Nonno
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

6.  Transmission of bovine spongiform encephalopathy to sheep and goats.

Authors:  J D Foster; J Hope; H Fraser
Journal:  Vet Rec       Date:  1993-10-02       Impact factor: 2.695

7.  Discrimination between scrapie and bovine spongiform encephalopathy in sheep by molecular size, immunoreactivity, and glycoprofile of prion protein.

Authors:  C M A Thuring; J H F Erkens; J G Jacobs; A Bossers; L J M Van Keulen; G J Garssen; F G Van Zijderveld; S J Ryder; M H Groschup; T Sweeney; J P M Langeveld
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

8.  Molecular screening of sheep for bovine spongiform encephalopathy.

Authors:  A F Hill; K C Sidle; S Joiner; P Keyes; T C Martin; M Dawson; J Collinge
Journal:  Neurosci Lett       Date:  1998-10-23       Impact factor: 3.046

9.  Immunohistochemical features of PrP(d) accumulation in natural and experimental goat transmissible spongiform encephalopathies.

Authors:  M Jeffrey; S Martin; L González; J Foster; J P M Langeveld; F G van Zijderveld; J Grassi; N Hunter
Journal:  J Comp Pathol       Date:  2006-03-20       Impact factor: 1.311

10.  Comparative molecular analysis of the abnormal prion protein in field scrapie cases and experimental bovine spongiform encephalopathy in sheep by use of Western blotting and immunohistochemical methods.

Authors:  Stéphane Lezmi; Stuart Martin; Stéphanie Simon; Emmanuel Comoy; Anna Bencsik; Jean-Philippe Deslys; Jacques Grassi; Martin Jeffrey; Thierry Baron
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more
  13 in total

1.  Differentiating ovine BSE from CH1641 scrapie by serial protein misfolding cyclic amplification.

Authors:  Maged M Taema; Ben C Maddison; Leigh Thorne; Keith Bishop; Jonathan Owen; Nora Hunter; Claire A Baker; Linda A Terry; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

2.  Attenuated live vaccine (Bartha-K16) caused pseudorabies (Aujeszky's disease) in sheep.

Authors:  Hanjin Kong; Keshan Zhang; Yongjie Liu; Youjun Shang; Bin Wu; Xiangtao Liu
Journal:  Vet Res Commun       Date:  2013-06-25       Impact factor: 2.459

3.  Highly sensitive detection of small ruminant bovine spongiform encephalopathy within transmissible spongiform encephalopathy mixes by serial protein misfolding cyclic amplification.

Authors:  Kevin C Gough; Keith Bishop; Ben C Maddison
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

4.  Genetic and Pathological Follow-Up Study of Goats Experimentally and Naturally Exposed to a Sheep Scrapie Isolate.

Authors:  Caterina Maestrale; Maria G Cancedda; Davide Pintus; Mariangela Masia; Romolo Nonno; Giuseppe Ru; Antonello Carta; Francesca Demontis; Cinzia Santucciu; Ciriaco Ligios
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

5.  Small ruminant nor98 prions share biochemical features with human gerstmann-sträussler-scheinker disease and variably protease-sensitive prionopathy.

Authors:  Laura Pirisinu; Romolo Nonno; Elena Esposito; Sylvie L Benestad; Pierluigi Gambetti; Umberto Agrimi; Wen-Quan Zou
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

6.  Biochemical characterization of prion strains in bank voles.

Authors:  Laura Pirisinu; Stefano Marcon; Michele Angelo Di Bari; Claudia D'Agostino; Umberto Agrimi; Romolo Nonno
Journal:  Pathogens       Date:  2013-07-02

7.  Isolation of a Defective Prion Mutant from Natural Scrapie.

Authors:  Ilaria Vanni; Sergio Migliore; Gian Mario Cosseddu; Michele Angelo Di Bari; Laura Pirisinu; Claudia D'Agostino; Geraldina Riccardi; Umberto Agrimi; Romolo Nonno
Journal:  PLoS Pathog       Date:  2016-11-23       Impact factor: 6.823

8.  Prion Disease in Dromedary Camels, Algeria.

Authors:  Baaissa Babelhadj; Michele Angelo Di Bari; Laura Pirisinu; Barbara Chiappini; Semir Bechir Suheil Gaouar; Geraldina Riccardi; Stefano Marcon; Umberto Agrimi; Romolo Nonno; Gabriele Vaccari
Journal:  Emerg Infect Dis       Date:  2018-06-17       Impact factor: 6.883

Review 9.  Methods for Differentiating Prion Types in Food-Producing Animals.

Authors:  Kevin C Gough; Helen C Rees; Sarah E Ives; Ben C Maddison
Journal:  Biology (Basel)       Date:  2015-11-13

10.  Novel Type of Chronic Wasting Disease Detected in Moose (Alces alces), Norway.

Authors:  Laura Pirisinu; Linh Tran; Barbara Chiappini; Ilaria Vanni; Michele A Di Bari; Gabriele Vaccari; Turid Vikøren; Knut Ivar Madslien; Jørn Våge; Terry Spraker; Gordon Mitchell; Aru Balachandran; Thierry Baron; Cristina Casalone; Christer M Rolandsen; Knut H Røed; Umberto Agrimi; Romolo Nonno; Sylvie L Benestad
Journal:  Emerg Infect Dis       Date:  2018-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.